VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).
Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop...
Citius Pharma (CTXR) $1.20. Price Target Upped to $4.00 at HC Wainright.
STREET INSIDER
H.C. Wainwright analyst Vernon Bernardino raised the price target on Citius Pharmaceuticals...
Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
Okay, so What’s Next for Citius Pharma (CTXR) $1.16?
Dawson James Broker/Dealer Updates. Price Target Remains at $7.00.
"OK, So what’s Next? Topline data from the superior efficacy...
Real Estate Wonder Redefy to go Public. Full-Service Real Estate Transactions for $3,500 Flat...
Redefy Holdings, Inc., Enters into Definitive Share Exchange Agreement to Become a Publicly Traded Company
DENVER, March 12,...
Institutional Analyst Newsletters. March.
Internet | Biotech | Beverages | Marijuana | Blockchain
The Institutional Analyst newsletter aggregates headlines from all our...
HCN Network. Like Investing in Uber or Lyft, When They Only had 9,000 Drivers?
Internet Stock Review Report on Hotel Communications Network.
HCN Communication Network has the most exciting Internet Advertising...
Kevin Bidner’s Hotel Communication Network.
Click to Read About the Most Exciting Internet Powered Media Network (Advertising) We've Seen in Decades.
The last time...
Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!
Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...